Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.
Fiche publication
Date publication
février 2021
Journal
Trials
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CHAMARAUX-TRAN Thiên-Nga
Tous les auteurs :
Muller M, Lefebvre F, Harlay ML, Glady L, Becker G, Muller C, Aberkane O, Tawk M, Julians M, Romoli A, Hecketsweiler S, Schneider F, Pottecher J, Chamaraux-Tran TN
Lien Pubmed
Résumé
The main objective of this study is to evaluate the effect of intravenous lidocaine on gas exchange and inflammation in acute respiratory distress syndrome due or not to Covid-19 pneumonia.
Mots clés
COVID-19, Randomised controlled trial, lidocaine, local anaesthetics, molecular mechanisms of pharmacological action, protocol, severe acute respiratory syndrome
Référence
Trials. 2021 Feb 11;22(1):131